Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neratinib in Older Patients with HER2+ Metastatic Breast Cancer
NCT02673398Phase 2Completed
- Sponsor
- City of Hope
- Start
- Dec 2016
- Primary completion
- Mar 2020
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of neratinib in breast cancer, sponsored by City of Hope. Started Dec 2016; status: completed.
02
Drugs
neratinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02673398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02673398.